Adults with relapsing MS rated the Sensoready pen, an autoinjector used to self-administer Kesimpta, for ease of use and ...

According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...

MS patients have significantly worse sleep quality than healthy people, despite similar sleep quantity, per a new review of ...

The following is a summary of “Real-world satisfaction and experience with injection and autoinjector device for ofatumumab ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, and will help health professionals navigate a treatment landscape that has ...

Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM) , a diversified, vertically integrated global healthcare ...

Scott, an internationally recognized neurologist and leader in multiple sclerosis (MS) research and clinical care, has been awarded the 2024 MS Research Award by MS Australia.